Large Volume Parenteral (LVP) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

Which drivers are expected to have the greatest impact on the over the large volume parenteral (lvp) market's growth?
The increasing instances of chronic diseases are projected to drive the expansion of the large-volume parenteral market. Chronic diseases are usually diseases or conditions that last for three months or more and have the potential to become increasingly severe over time. The surge in chronic diseases is primarily due to tobacco consumption, second-hand smoke exposure, and an unhealthy diet. Patients with these conditions need a correctly balanced intake of crucial nutrients that aid in strength maintenance. The parenteral route of drug administration aids in providing the precise drug dosage, as the majority of the drug bypasses the digestive system and is directly absorbed into the bloodstream. For example, as reported by the World Health Organization, a Switzerland-based division of the United Nations, in September 2023, 41 million deaths annually, accounting for 74% of total deaths, are caused by non-communicable diseases (NCDs) or chronic diseases worldwide. Hence, the escalating prevalence of chronic diseases is propelling the growth of the large-volume parenteral market.

Get Your Large Volume Parenteral (LVP) Market Report Here:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

What is the future CAGR of the large volume parenteral (lvp) market, and how will it impact industry expansion?
Recent years have seen robust growth in the size of the large volume parenteral (LVP) market. The market, which is valued at $12.52 billion in 2024, is projected to reach $13.57 billion in 2025, growing at a compounded annual rate of 8.3%. This substantial growth over the years can be credited to factors such as the rise in chronic disease cases, an expanding aging population, increased demand for sterile pharmaceuticals, growth in healthcare infrastructure, and the development of regulatory policies pertaining to pharmaceuticals.

In the coming years, the market size of Large Volume Parenteral (LVP) is projected to witness considerable growth, culminating to a market value of $19.46 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.4%. This projected growth within the forecast period can be linked to the increasing demand for biologics and biosimilars, a surge in healthcare expenditure, proliferation of pharmaceutical outsourcing, an escalating focus on tailored medicine, and the worldwide expansion of pharmaceutical supply chains. Noteworthy trends for the forecast duration include technological innovations in manufacturing procedures, the incorporation of superior technologies into the pharmaceutical production process, the adoption of single-use technologies, creation of high-concentration formulas, and the rise in 3D printing applications within the pharmaceutical industry.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

What are the most significant trends transforming the large volume parenteral (lvp) market today?
The trend of product innovation is gaining traction in the large-volume parenteral market, with key market participants focusing on pioneering product development to fortify their market standing. For instance, in March 2022, SGD Pharma SA, a French enterprise specializing in manufacturing molded and tubular glass for primary pharmaceutical packaging, introduced 100-ml type I molded glass vials. These sterile vials are primed for aseptic filling and finalizing of parenteral medication formulations. They contribute to shielding vials from scratching, facilitate the visual inspection of the filled vial, and reduce the potential for rejection in quality control.

Which key market segments comprise the large volume parenteral (lvp) market and drive its revenue growth?
The large volume parenteral (LVP) market covered in this report is segmented -

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) By Volume: 100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML -2000 ML, 2000 And More
3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:
1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags
2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags
3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12195

What regions are at the forefront of large volume parenteral (lvp) market expansion?
North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the large volume parenteral (lvp) market?
Major companies operating in the large volume parenteral (LVP) market include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

What Is Covered In The Large Volume Parenteral (LVP) Global Market Report?

• Market Size Forecast: Examine the large volume parenteral (lvp) market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the large volume parenteral (lvp) market for a structured understanding.
• Key Players Overview: Analyze major players in the large volume parenteral (lvp) market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the large volume parenteral (lvp) market.
• Segment Contributions: Evaluate how different segments drive overall growth in the large volume parenteral (lvp) market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the large volume parenteral (lvp) market.
• Industry Challenges: Identify potential risks and obstacles affecting the large volume parenteral (lvp) market.
• Competitive Landscape: Review strategic developments in the large volume parenteral (lvp) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.